ISHLT Research Grant for Molecular Diagnostics and Precision Medicine in Heart Transplantation supports researchers studying molecular diagnostics to guide immunosuppression and improve long-term transplant outcomes.
Funder: International Society for Heart and Lung Transplantation
Due Dates: January 19, 2027 (Application deadline)
Funding Amounts: Two awards of up to $40,000 USD each for one year
Summary: Supports molecular diagnostics research to guide immunosuppression and improve long-term outcomes in adult heart transplantation.
Key Information: Applicants must be active ISHLT members or have submitted a completed membership application by September 30.
The International Society for Heart and Lung Transplantation (ISHLT), with support from CareDx, funds research advancing precision medicine in adult heart transplantation. The program emphasizes donor-derived cell-free DNA (dd-cfDNA) and gene expression profiling (GEP), especially in combination, to optimize immunosuppression management and improve outcomes beyond the first three years after transplantation.
Research priorities include biomarker-guided immunosuppression minimization and identifying patients who can safely tolerate reduced immunosuppressive exposure. Other priorities include relationships between molecular test results and malignancy, advanced chronic kidney disease, or cardiac allograft vasculopathy; the clinical utility of testing more than three to five years after transplantation; and surveillance strategies that improve long-term graft health and patient outcomes.